On the occasion of the 60th anniversary of the Slovenian Association of Friends of Youth, volunteers from Lek, a Sandoz Company, raised more than 25,000 Euros for Children’s Helpline
This year’s Community Partnership Day, which will take place on April 25 in Slovenia, kicked-off last week by 12 of our associates who raised more than 25,000 Euros for the Children’s Helpline as a part of the 60th anniversary celebration of the SAFY.
On Friday, April 12, an event on the occasion of the 60th anniversary of the Slovenian Association of Friends of Youth was held in Cankarjev dom in a very positively charged atmosphere, where some well-known Slovenes described the hardships they faced themselves when growing up and how useful a children’s helpline such as TOM Telephone would have been to them.
TOM is a helpline for children and youths who face the challenges and pitfalls of growing up as well as for those at risk who may experience all kinds of difficulties and problems.
Throughout the event, a phone line was open to raise funds for the TOM helpline. The calls were answered by our associates – volunteers who helped raise more than 25,000 Euros.
»We have a long-term partnership with the Slovenian Association of Friends of Youth and we have gladly decided to help them celebrate their remarkable 60 years of operation. As a part of Novartis Global Volunteer Day, 12 associates volunteered to help in the call center. Raising funds and chatting to people of good will and good intentions is a wonderful experience, so that once again, as in all other projects that we co-create together with Friends of Youth, we enrich ourselves,« said one of the volunteers, Miran Šinigoj, an associate of Information Technology from Lek, a Sandoz company.
About Lek’s partnership with SAFY
Lek, a Sandoz company, has been cooperating with the Slovenian Association of Friends of Youth for many years. Of key importance is their partnership in the Wink at the Sun humanitarian campaign that Lek and SAFY have been jointly creating for nearly 15 years. Furthermore, Lek works hand in hand with SAFY on the occasion of Child’s Week which is held every first week in October and supports the organisation of gathering of history club mentors.
The aim of the »A Wink at the Sun« humanitarian campaign is to enable free organised holidays for children from socially disadvantaged backgrounds. To date, more than 1.5 million Euros were raised and nearly 9,000 kids enjoyed free holidays.
In all the years of co-creating the Wink at the Sun, we allocated over 200,000 Euros to this humanitarian campaign and organised 22 Lek Sunshine games. This is a special fun event which makes the children’s summer holidays even brighter. Namely, we wanted to offer the children vacationing at SAFY holiday resorts something more than merely financial support. Therefore, together with SAFY, we created the Sunshine games (today Lek Sunshine games) which have been held twice a year since 2001, in order to further brighten the children’s holidays.
Lek, a Sandoz company, is one of key pillars of the second-largest generic pharmaceutical company globally. Its role within Sandoz is to act as: a leading global development center for products and technologies; a global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar products; and, a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and Commonwealth of Independent States (CIS), and it is responsible for sales on the Slovenian market. For further information please visit http://www.lek.si/eng/.
Sandoz, a Division of the Novartis group, is the second-largest generic pharmaceuticals company globally, offering a broad range of over 1,000 high-quality, affordable products that are no longer protected by patents. With approximately 25,000 employees in 140 countries, Sandoz holds the #1 position globally in biosimilars as well as generic injectables, ophthalmics, dermatology and antibiotics. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany), Eon Labs (US), EBEWE Pharma (Austria), Oriel Therapeutics (US) and Fougera Pharmaceuticals (US). In 2012, Sandoz posted sales of USD 8.7 billion. For more information, please visit www.sandoz.com.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2012, the Group achieved net sales of USD 56.7 billion, while R&D throughout the Group amounted to approximately USD 9.3 billion (USD 9.1 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 128,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
Fax: +386 1 580 24 32